Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-126207
Filing Date
2020-04-29
Accepted
2020-04-29 16:15:22
Documents
7
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A d903181ddefa14a.htm DEFA14A 44820
2 GRAPHIC g903181g10p88.jpg GRAPHIC 2727
3 GRAPHIC g903181g12s22.jpg GRAPHIC 3863
4 GRAPHIC g903181g15q77.jpg GRAPHIC 2455
5 GRAPHIC g903181g18o45.jpg GRAPHIC 2439
6 GRAPHIC g903181g36z46.jpg GRAPHIC 2537
7 GRAPHIC g903181g65m33.jpg GRAPHIC 15737
  Complete submission text file 0001193125-20-126207.txt   87791
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 20830490
SIC: 2834 Pharmaceutical Preparations